CD24 and hepatocellular carcinoma: As few as 10 CD24+CD133+ liver CSCs could initiate tumorigenicity in NOD/SCID mice, and patients with CD24+CD133+ liver CSCs have worse clinical outcome, revealing the critical role of CD24+CD133+ CSCs in HCC tumorigenesis (5).